NEW YORK (GenomeWeb News) — GeneWorks will distribute Ariadne’s pathway-analysis software in Australia and New Zealand, the companies said today.
 
Under the agreement, Australia-based GeneWorks will distribute Ariadne’s Pathway Studio, which is used to analyze and interpret data from high-throughput research, to its regional clients, the companies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.